Tuesday, May 28, 2019

Europe Point of Care Testing Market Size, Share Analysis Report Forecast to 2024 | Research Cosmos


Europe Point of Care Testing Market Size and Growth Rate:

Europe Point Of Care Testing Market is anticipated to reach USD 11,682.540 billion by 2024 from USD 6,051.50 billion in 2016, at a CAGR of 8.60% in the projection period 2017 to 2024.

Browse 120 Pages of Research Report developed on Europe Point of Care Testing Market @ https://www.researchcosmos.com/reports/europe-point-of-care-testing-market/29411909

Europe Point of Care Testing Market Overview:

Recently, the diagnostic market for breastfeeding families has grown exponentially, with a growing preference for patients performing these tests. The factor that helps the European PoC market to develop tremendously is the technological advances that have developed in the medical field for many years. Point of care equipment is defined as a medical device used to obtain immediate results in diagnosis and surveillance of various diseases such as cancer, diabetes and heart disease. The demand for devices is expected to increase due to the continued development of R&D activities for the miniaturization of molecular and special diagnostic tests. Some initiatives by governments and non-governmental organizations to strengthen European industry trends in various epidemics and improve health literacy. This equipment is particularly easy to use due to the lack of diagnostic specialists and medical staff.

Europe Point of Care Testing Market Growth Drivers and Restraints:

There is an accelerating growth in the regional market with the improving automation laboratory technology and introducing advanced and cost-effective medical solutions. Main technical advances in diagnosis, introduction of basic essences at home; and rising medical costs are also supporting the growth of the market. Automated lab systems and highly integrated solutions facilitate diagnostic workflows, facilitating the adoption of diagnostic and test products as needed.
However, government regulations on product approvals and reimbursements for point-of-service devices significantly restrict market growth. Research and development activities among point of care diagnostics devices for the rapid detection and control of key diseases, and introducing new inspections are expected to drive industrial development.Market participants are constantly focusing on research and development to help grow the market through the innovation of new, and more efficient devices.

One of the key drivers of growth in the European point of care testing market is the growing demand for rapid diagnostic procedures with the proliferation of chronic diseases in the region. Government contracts contributing to the development of on-site diagnostic devices should accelerate future market growth.


Europe Point of Care Testing Market Geographical Segmentation:

Germany was the largest market in Europe with sales of more than $ 740 million in 2018. This is due to favorable government regulations, a well-developed medical infrastructure and a large population.

Key Players of the Europe Point of Care Testing Market:

The main market players are Danaher Corporation; F. Hoffmann-La Roche Ltd; Abbott Laboratories; SpA instrumentation laboratory; bioMérieux SA; Trividia Health, Inc .; QIAGEN; Becton Dickinson & Company; New biomedical sciences; Sekisui Diagnostics LLC; I Siemens Healthcare GmbH; Quidel Corporation.


About Us:

Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.

Contact:

Kevin Stewart
Global Sales Manager
Research Cosmos

No comments:

Post a Comment